Lipid-based nanosystem of edaravone: development, optimization, characterization and in vitro/in vivo evaluation

Edaravone (EDR) is a well-recognized lipophilic free radical scavenger for diseases including neurodegenerative disease, cardiovascular disease, and cancer. However, its oral use is restricted due to poor oral bioavailability (BA). The aim of present research was to enable its oral use by developing...

Descripción completa

Detalles Bibliográficos
Autores principales: Parikh, Ankit, Kathawala, Krishna, Tan, Chun Chuan, Garg, Sanjay, Zhou, Xin-Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241028/
https://www.ncbi.nlm.nih.gov/pubmed/28633547
http://dx.doi.org/10.1080/10717544.2017.1337825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241028/
https://www.ncbi.nlm.nih.gov/pubmed/28633547
http://dx.doi.org/10.1080/10717544.2017.1337825

Ejemplares similares